Resilience and vulnerabilities of tumor cells under purine shortage stress

|

|

Summary

This summary is machine-generated.

Cancer cells adapt to purine shortage by forming purinosomes and utilizing purine salvage pathways. This adaptation creates vulnerabilities to microtubule-targeting drugs and highlights MTAP inhibition as a potential cancer therapy.

Area Of Science

  • Cancer Biology
  • Metabolic Pathways
  • Drug Discovery

Background

  • Purine metabolism is a critical target in cancer therapy.
  • Understanding cancer cell adaptation to purine scarcity is essential for developing effective treatments.
  • The roles of de novo purine biosynthesis and salvage pathways in cancer under stress are not fully elucidated.

Purpose Of The Study

  • To investigate how cancer cells respond to purine shortage.
  • To identify adaptive mechanisms and vulnerabilities in cancer cells under purine deprivation.
  • To explore therapeutic strategies targeting purine metabolism in cancer.

Main Methods

  • Utilized the purine shortage-inducing prodrug DRP-104.
  • Employed genetic approaches in prostate, lung, and glioma cancer models.
  • Investigated the role of microtubules, purinosomes, and Methylthioadenosine Phosphorylase (MTAP) in purine metabolism.

Main Results

  • Cancer cells form purinosomes (multi-protein complexes) to enhance de novo purine biosynthesis under stress.
  • Purinosome formation increases susceptibility to microtubule-stabilizing drugs like Docetaxel.
  • MTAP-mediated purine salvage is crucial for cancer cell survival under purine shortage.
  • Combining DRP-104 with an MTAP inhibitor significantly suppressed prostate tumors in vivo.
  • Purine-starved cancer cells show increased DNA damage and cGAS-STING pathway activation, potentially impairing immunoevasion.

Conclusions

  • Purinosome assembly and MTAP-mediated purine salvage are key adaptive mechanisms enabling cancer cell resilience to purine shortage.
  • Microtubules, MTAP, and impaired immunoevasion represent significant therapeutic vulnerabilities in purine-deprived cancer cells.
  • Targeting purine metabolism, particularly in combination with MTAP inhibition, offers a promising strategy for cancer treatment.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells 02:53

5.6K

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Treatment Resistant Cancers 02:56

3.2K

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Abnormal Proliferation 02:23

4.4K

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Cancer Stem Cells and Tumor Maintenance 02:40

4.7K

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

Cancer-Critical Genes II: Tumor Suppressor Genes 01:05

7.3K

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

DNA Damage can Stall the Cell Cycle 02:37

9.0K

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...